Home » Topics » BioWorld Science, Immune

BioWorld Science, Immune
RSS

First subjects dosed in phase I study of PN-235

Dec. 17, 2020

NP + GPC DNA vaccine candidate protects cynomolgus macaques from Crimean-Congo hemorrhagic fever

Dec. 17, 2020

Galapagos discloses new SIK inhibitors

Dec. 17, 2020

mRNA SARS-CoV-2 vaccines to usher in 'golden age of vaccinology'

Dec. 7, 2020

Chugai describes antigen-binding molecules targeting C1s

Dec. 4, 2020

Hookipa reports interim phase II data on prophylactic CMV vaccine candidate HB-101

Nov. 30, 2020

Idorsia Pharmaceuticals synthesizes new PDK1 inhibitors

Nov. 27, 2020

European Commission approves quadrivalent meningococcal conjugate vaccine MenQuadfi

Nov. 23, 2020

Slowing cholera down protects survivors of infection

Nov. 23, 2020

Supemtek quadrivalent recombinant influenza vaccine approved in E.U.

Nov. 19, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 17, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...